Analysts Set Astera Labs, Inc. (NASDAQ:ALAB) PT at $275.75

Astera Labs, Inc. (NASDAQ:ALAB) has been given an average recommendation of “Moderate Buy” by the twenty-three brokerages that are currently covering the company, Marketbeat.com reports. Eleven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 1-year target price among analysts that have covered the stock in the last year is $282.00.

ALAB has been the topic of a number of research analyst reports. Barclays upped their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday. Royal Bank Of Canada lifted their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Finally, Susquehanna raised their target price on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th.

Astera Labs Price Performance

ALAB opened at $319.79 on Friday. The firm has a market capitalization of $54.82 billion, a P/E ratio of 216.07, a price-to-earnings-growth ratio of 3.51 and a beta of 3.66. Astera Labs has a one year low of $97.89 and a one year high of $499.48. The company has a fifty day moving average price of $353.67 and a 200-day moving average price of $223.00.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue was up 93.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts expect that Astera Labs will post 1.86 earnings per share for the current year.

Insider Activity at Astera Labs

In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $1,577,250.00. Following the transaction, the director owned 57,466 shares of the company’s stock, valued at $25,859,700. This represents a 5.75% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the sale, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,676,845 shares of company stock worth $444,928,806 in the last three months. 10.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Astera Labs

A number of hedge funds and other institutional investors have recently modified their holdings of ALAB. Atreides Management LP raised its holdings in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Amundi lifted its position in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares during the last quarter. Artisan Partners Limited Partnership purchased a new stake in Astera Labs in the fourth quarter worth approximately $148,980,000. Goldman Sachs Group Inc. boosted its stake in Astera Labs by 189.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after buying an additional 858,693 shares in the last quarter. Finally, State Street Corp grew its position in Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after acquiring an additional 760,358 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.